Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ADPTADPT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in Adaptive Biotechnologies Corp.

GOLDMAN SACHS GROUP INC holds 3M shares of ADPT (Adaptive Biotechnologies Corp.), worth $64M as of 2026-Q2. The position was decreased (-8.0% shares). ADPT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$64M

Current Shares

3M

Total Value Change

+$50.6M

Total Shares Change

+746,101

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3M
-8.0%
$64M0.0%$21.45
0
2026-Q1
Increased
3.2M
+11.7%
$45M0.0%$16.08
33
2025-Q4
Increased
2.9M
+54.4%
$47.1M0.0%$16.42
41
2025-Q3
Decreased
1.9M
-2.5%
$28.1M0.0%$13.46
0
2025-Q2
Decreased
1.9M
-3.9%
$22.5M0.0%$11.79
0
2025-Q1
Decreased
2M
-10.4%
$14.9M0.0%$7.67
0
2024-Q4
New
2.2M
-
$13.4M0.0%$6.11
39

Other major holders of ADPT: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used